Laboratory of Lyon, Antimicrobial Resistance and Bacterial Virulence Unit, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), University of Lyon, 31 avenue Tony Garnier, 69007Lyon, France.
Laboratory of Lyon, Epidemiology and Support to Surveillance Unit, French Agency for Food, Environmental and Occupational Health and Safety (ANSES), University of Lyon, 31 avenue Tony Garnier, 69007Lyon, France.
Epidemiol Infect. 2021 Apr 20;149:e104. doi: 10.1017/S0950268821000856.
Antimicrobial resistance is a One Health issue requiring the development of surveillance systems in the human, environmental and animal sectors. In the European Economic Area, the surveillance of antimicrobial resistance in zoonotic pathogens and indicator bacteria in healthy food-producing animals is required legally, while countries are also expected to extend their surveillance to diseased animals in the frame of national action plans. In this context, evaluating existing antimicrobial resistance surveillance systems in animal health is important to improve systems in place, but also to help other countries learn from these experiences, understand success factors and anticipate challenges. With this aim, the French surveillance network for antimicrobial resistance in bacteria from diseased animals (RESAPATH) was evaluated using the Outil d'Analyse des Systèmes d'Information en Santé (OASIS) assessment tool. Key performance factors included (i) a strong and inclusive central institutional organisation defining clear and well-accepted surveillance objectives, scope and procedures, (ii) strong skills in epidemiology and microbiology and (iii) a win-win approach enabling the voluntary participation of 71 field laboratories and where free annual proficiency testing plays a pivotal role. The main area for improvement of RESAPATH was its time-consuming data management system.
抗微生物药物耐药性是一个涉及人类、环境和动物健康的问题,需要在这三个领域开发监测系统。在欧洲经济区,法律要求对人畜共患病病原体和健康食用动物中指示菌的抗微生物药物耐药性进行监测,同时各国还需要在国家行动计划框架内,将监测范围扩大到患病动物。在这种情况下,评估动物健康领域现有的抗微生物药物耐药性监测系统对于改进现有系统以及帮助其他国家借鉴这些经验、了解成功因素和预测挑战都很重要。为此,使用 Outil d'Analyse des Systèmes d'Information en Santé(OASIS)评估工具对法国动物疾病细菌抗微生物药物耐药性监测网络(RESAPATH)进行了评估。关键绩效因素包括:(i)一个强大而包容的中央机构组织,确定明确且被广泛接受的监测目标、范围和程序;(ii)具备流行病学和微生物学方面的强大技能;(iii)采用双赢的方法,使 71 个现场实验室自愿参与,其中免费的年度能力验证发挥着关键作用。RESAPATH 需要改进的主要领域是其耗时的数据管理系统。